RetinalGenix Technologies Inc. – OTC:RTGN
RetinalGenix Technologies stock price today
RetinalGenix Technologies stock price monthly change
RetinalGenix Technologies stock price quarterly change
RetinalGenix Technologies stock price yearly change
RetinalGenix Technologies key metrics
Market Cap | 28.94M |
Enterprise value | 140.30M |
P/E | -40.90 |
EV/Sales | N/A |
EV/EBITDA | -43.37 |
Price/Sales | N/A |
Price/Book | -131.19 |
PEG ratio | 0.64 |
EPS | -0.21 |
Revenue | N/A |
EBITDA | -3.72M |
Income | -3.72M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRetinalGenix Technologies stock price history
RetinalGenix Technologies stock forecast
RetinalGenix Technologies financial statements
| Jun 2023 | 0 | -352.14K | |
|---|---|---|---|
| Sep 2023 | 0 | -686.46K | |
| Dec 2023 | 150 | -541.63K | -361090.67% |
| Mar 2024 | 0 | -2.14M |
| Jun 2023 | 2119 | 1.77M | 83857.95% |
|---|---|---|---|
| Sep 2023 | 225 | 1.08M | 481224.44% |
| Dec 2023 | 156 | 1.40M | 901162.18% |
| Mar 2024 | 50517 | 1.56M | 3106.57% |
| Jun 2023 | -123.81K | 0 | 118.25K |
|---|---|---|---|
| Sep 2023 | 39.74K | 0 | -41.61K |
| Dec 2023 | -186.75K | 0 | 186.70K |
| Mar 2024 | -142.86K | 0 | 193.25K |
RetinalGenix Technologies other data
-
What's the price of RetinalGenix Technologies stock today?
One share of RetinalGenix Technologies stock can currently be purchased for approximately $3.54.
-
When is RetinalGenix Technologies's next earnings date?
Unfortunately, RetinalGenix Technologies's (RTGN) next earnings date is currently unknown.
-
Does RetinalGenix Technologies pay dividends?
No, RetinalGenix Technologies does not pay dividends.
-
How much money does RetinalGenix Technologies make?
RetinalGenix Technologies has a market capitalization of 28.94M.
-
What is RetinalGenix Technologies's stock symbol?
RetinalGenix Technologies Inc. is traded on the OTC under the ticker symbol "RTGN".
-
What is RetinalGenix Technologies's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of RetinalGenix Technologies?
Shares of RetinalGenix Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When RetinalGenix Technologies went public?
RetinalGenix Technologies Inc. is publicly traded company for more then 3 years since IPO on 24 Feb 2022.
-
What is RetinalGenix Technologies's official website?
The official website for RetinalGenix Technologies is retinalgenix.com.
-
Where are RetinalGenix Technologies's headquarters?
RetinalGenix Technologies is headquartered at 1450 North Mcdowell Boulevard, Petaluma, CA.
-
How can i contact RetinalGenix Technologies?
RetinalGenix Technologies's mailing address is 1450 North Mcdowell Boulevard, Petaluma, CA and company can be reached via phone at +41 55789583.
RetinalGenix Technologies company profile:
RetinalGenix Technologies Inc.
retinalgenix.comOTC
0
Medical - Devices
Healthcare
RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is headquartered in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
Petaluma, CA 94954
CIK: 0001836295
ISIN: US76133Y1055
:
